Commentary
Increasing evidences suggest that a correlation exists between NAFLD/NASH and central nervous system diseases or dysfunctions such as depression, mild cognitive impairment, Alzheimer’s disease, and dementia.
In this review, M. Colognesi et al. (University of Padova, Italy) summarise the main correlations observed between NAFLD development and CNS dysfunctions, focusing on the studies investigating the mechanisms involved in this association.
